This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Nov 4;385(19):e67.

doi: 10.1056/NEJMc2114593.

More on CD19-CAR T Cells in Systemic Lupus Erythematosus

Maximilian F Konig¹, Suman Paul¹

Affiliations

PMID: 34731550
DOI: 10.1056/NEJMc2114593

Comment

More on CD19-CAR T Cells in Systemic Lupus Erythematosus

Maximilian F Konig et al. N Engl J Med. 2021.

. 2021 Nov 4;385(19):e67.

doi: 10.1056/NEJMc2114593.

Authors

Maximilian F Konig¹, Suman Paul¹

Affiliation

¹ Johns Hopkins University School of Medicine, Baltimore, MD konig@jhmi.edu.

PMID: 34731550
DOI: 10.1056/NEJMc2114593

No abstract available

PubMed Disclaimer

Comment in

More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
Mougiakakos D, Krönke G, Schett G. Mougiakakos D, et al. N Engl J Med. 2021 Nov 4;385(19):e67. doi: 10.1056/NEJMc2114593. N Engl J Med. 2021. PMID: 34731551 No abstract available.

Comment on

CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, Manger B, Mackensen A, Schett G. Mougiakakos D, et al. N Engl J Med. 2021 Aug 5;385(6):567-569. doi: 10.1056/NEJMc2107725. N Engl J Med. 2021. PMID: 34347960 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information